The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer

Cholesterol

Volumn 2011, Issue , 2011, Pages

  McGrowder, Donovan ^a   Riley, Cliff ^b   Morrison, Errol Y St A ^b   Gordon, Lorenzo ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY OF TECHNOLOGY   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; DYSLIPIDEMIA; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LUNG CANCER; NEOPLASM; NEUROPROTECTION; NONHODGKIN LYMPHOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 79955089807     PISSN: 20901283     EISSN: 20901291     Source Type: Journal    
DOI: 10.1155/2011/496925     Document Type: Review

References (102)

1. Barter P., Kastelein J., Nunn A., Hobbs R., Shepherd J., Ballantyne C., Brown V., Bruckert E., Carmena R., Davidson M., Davignon J., Fruchart J. -C., Gotto A., Genest J., Krone W., Leiter L., Olsson A., Packard C., Paoletti R., Saito Y., Tonkin A., High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions Atherosclerosis 2003 168 2 195 211 (Pubitemid 36703318)
2. Shah P. K., Kaul S., Nilsson J., Cercek B., Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I Circulation 2001 104 19 2376 2383 (Pubitemid 33049524)
3. Albers J. J., Tollefson J. H., Chen C. H., Steinmetz A., Isolation and characterization of human plasma lipid transfer proteins Arteriosclerosis 1984 4 1 49 58 (Pubitemid 14222596)
4. Skinner E. R., High-density lipoprotein subclasses Current Opinion in Lipidology 1994 5 3 241 247 (Pubitemid 24198822)
5. Gotto A. M., Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report Circulation 2001 103 17 2213 2218
6. Drexel H., Reducing risk by raising HDL-cholesterol: the evidence European Heart Journal, Supplement 2006 8 F23 F29
7. Toth P. P., High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies American Journal of Cardiology 2005 96 9 50K 58K (Pubitemid 41598113)
8. Gordon D. J., Probstfield J. L., Garrison R. J., Neaton J. D., Castelli W. P., Knoke J. D., Jacobs D. R. Jr., Bangdiwala S., Tyroler H. A., High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 1989 79 1 8 15 (Pubitemid 19043669)
9. Castelli W. P., Cholesterol and lipids in the risk of coronary artery disease. The Framingham Heart Study Canadian Journal of Cardiology 1988 4 supplement A 5 10
10. Goldbourt U., Yaari S., Medalie J. H., Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: a 21-year follow-up of 8000 men Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 1 107 113 (Pubitemid 27057331)
11. Stampfer M. J., Sacks F. M., Salvini S., Willett W. C., Hennekens C. H., A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction The New England Journal of Medicine 1991 325 6 373 381
12. Assmann G., Cullen P., Schulte H., The Mnster Heart Study (PROCAM). Results of follow-up at 8 years European Heart Journal 1998 19 A2 A11
13. Kannel W. B., Range of serum cholesterol values in the population developing coronary artery disease American Journal of Cardiology 1995 76 9 69C 77C
14. Capuzzi D. M., Guyton J. R., Morgan J. M., Goldberg A. C., Kreisberg R. A., Brusco O. A., Brody J., Efficacy and safety of an extended-release niacin (Niaspan): a long-term study American Journal of Cardiology 1998 82 12 74U 81U (Pubitemid 29044485)
15. Guyton J. R., Goldberg A. C., Kreisberg R. A., Sprecher D. L., Superko H. R., O'Connor C. M., Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia American Journal of Cardiology 1998 82 6 737 743
16. McKenney J. M., McCormick L. S., Weiss S., Koren M., Kafonek S., Black D. M., A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia American Journal of Medicine 1998 104 2 137 143 (Pubitemid 28117407)
17. Castelli W. P., Garrison R. J., Wilson P. W. F., Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study Journal of the American Medical Association 1986 256 20 2835 2838 (Pubitemid 17178361)
18. Taylor A. J., Lee H. J., Sullenberger L. E., The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3 Current Medical Research and Opinion 2006 22 11 2243 2250 (Pubitemid 44789989)
19. Rubins H. B., Robins S. J., Collins D., Fye C. L., Anderson J. W., Elam M. B., Faas F. H., Linares E., Schaefer E. J., Schectman G., Wilt T. J., Wittes J., Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol New England Journal of Medicine 1999 341 6 410 418 (Pubitemid 29362514)
20. Frick M. H., Elo O., Haapa K., Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease New England Journal of Medicine 1987 317 20 1237 1245 (Pubitemid 17147964)
21. Desprs J. P., Lemieux I., Robins S. J., Role of fibric acid derivatives in the management of risk factors for coronary heart disease Drugs 2004 64 19 2177 2198 (Pubitemid 39382208)
22. Csszr A., Hypertriglyceridemia, the coronary heart disease risk marker "solved" Acta Physiologica Hungarica 2005 92 2 109 120
23. Meade T., Zuhrie R., Cook C., Cooper J., Bezafibrate in men with lower extremity arterial disease: randomised controlled trial British Medical Journal 2002 325 7373 1139 1141 (Pubitemid 35398706)
24. Keech A., Simes R. J., Barter P., Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial The Lancet 2005 366 9500 1849 1861
25. Lewis G. F., Rader D. J., New insights into the regulation of HDL metabolism and reverse cholesterol transport Circulation Research 2005 96 12 1221 1232 (Pubitemid 40962099)
26. Robinson J. G., Davidson M. H., Investigational drugs targeting HDL-C metabolism and reverse cholesterol transport Future Lipidology 2007 2 3 285 301 (Pubitemid 46916282)
27. Chapman M. J., Assmann G., Fruchart J. C., Shepherd J., Sirtori C., Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acida position paper developed by the European Consensus Panel on HDL-C Current Medical Research and Opinion 2004 20 8 1253 1268 (Pubitemid 39120790)
28. Watson A. D., Berliner J. A., Hama S. Y., La Du B. N., Faull K. F., Fogelman A. M., Navab M., Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein Journal of Clinical Investigation 1995 96 6 2882 2891
29. Mackness B., Durrington P., McElduff P., Yarnell J., Azam N., Watt M., Mackness M., Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study Circulation 2003 107 22 2775 2779 (Pubitemid 36705985)
30. Hedrick C. C., Thorpe S. R., Fu M. X., Harper C. M., Yoo J., Kim S. M., Wong H., Peters A. L., Glycation impairs high-density lipoprotein function Diabetologia 2000 43 3 312 320 (Pubitemid 30163474)
31. Abbott C. A., Mackness M. I., Kumar S., Boulton A. J., Durrington P. N., Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 11 1812 1818
32. Nofer J. R., Kehrel B., Fobker M., Levkau B., Assmann G., Eckardstein A. V., HDL and arteriosclerosis: beyond reverse cholesterol transport Atherosclerosis 2002 161 1 1 16 (Pubitemid 34214816)
33. Chan N. N., Colhoun H. M., Vallance P., Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population Journal of the American College of Cardiology 2001 38 7 1814 1820 (Pubitemid 33116549)
34. Lupattelli G., Marchesi S., Roscini A. R., Siepi D., Gemelli F., Pirro M., Sinzinger H., Schillaci G., Mannarino E., Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia American Journal of Cardiology 2002 90 6 648 650 (Pubitemid 35264546)
35. O'Brien S. F., Watts G. F., Playford D. A., Burke V., O'Neal D. N., Best J. D., Low-density lipoprotein size, highdensity lipoprotein concentration, and endothelial dysfunction in non-insulindependent diabetes Diabetic Medicine 1997 14 11 974 978
36. Zhang X. Y., Zhao S. P., Li X. P., Gao M., Zhou QI. C., Endothelium-dependent and -independent functions are impaired in patients with coronary heart disease Atherosclerosis 2000 149 1 19 24 (Pubitemid 30125967)
37. Conlan M. G., Folsom A. R., Finch A., Davis C. E., Sorlie P., Marcucci G., Wu K. K., Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study Thrombosis and Haemostasis 1993 70 3 380 385 (Pubitemid 23254660)
38. Boyd N. F., McGuire V., Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer Journal of the National Cancer Institute 1990 82 6 460 468 (Pubitemid 20108048)
39. Gospodarowicz D., Lui G. M., Gonzalez R., High-density lipoproteins and the proliferation of human tumor cells maintained on extracellular matrix-coated dishes and exposed to defined medium Cancer Research 1982 42 9 3704 3713 (Pubitemid 12054483)
40. Rotheneder M., Kostner G. M., Effects of low- and high-density lipoproteins on the proliferation of human breast cancer cells in vitro: differences between hormone-dependent and hormone-independent cell lines International Journal of Cancer 1989 43 5 875 879 (Pubitemid 19138197)
41. Nofer J. R., Junker R., Pulawski E., Fobker M., Levkau B., Von Eckardstein A., Seedorf U., Assmann G., Walter M., High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway Thrombosis and Haemostasis 2001 85 4 730 735 (Pubitemid 32293712)
42. Nofer J. R., Levkau B., Wolinska I., Junker R., Fobker M., Von Eckardstein A., Seedorf U., Assmann G., Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids Journal of Biological Chemistry 2001 276 37 34480 34485
43. Knapp M. L., Al-Sheibani S., Riches P. G., Alterations of serum lipids in breast cancer: effects of disease activity, treatment, and hormonal factors Clinical Chemistry 1991 37 12 2093 2101 (Pubitemid 21925906)
44. Hoyer A. P., Engholm G., Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women Cancer Causes and Control 1992 3 5 403 408
45. Gaard M., Tretli S., Urdal F., Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women Cancer Causes and Control 1994 5 6 501 509 (Pubitemid 24335712)
46. Bani I. A., Williams C. M., Boulter P. S., Dickerson J. W. T., Plasma lipids and prolactin in patients with breast cancer British Journal of Cancer 1986 54 3 439 446 (Pubitemid 16031546)
47. Kokoglu E., Karaarslan I., Karaarslan H. M., Baloglu H., Alterations of serum lipids and lipoproteins in breast cancer Cancer Letters 1994 82 2 175 178 (Pubitemid 24231982)
48. Schreier L. E., Berg G. A., Basilio F. M., Lopez G. I., Etkin A. E., Wikinski R. L., Lipoprotein alterations, abdominal fat distribution and breast cancer Biochemistry and Molecular Biology International 1999 47 4 681 690 (Pubitemid 29195390)
49. Ray G., Husain S. A., Role of lipids, lipoproteins and vitamins in women with breast cancer Clinical Biochemistry 2001 34 1 71 76 (Pubitemid 32178509)
50. Furberg A. S., Veierd M. B., Wilsgaard T., Berstein L., Thune I., Serum high density lipoprotein cholesterol, metabolic profile, and breast cancer risk Journal of the National Cancer Institute 2004 96 15 1152 1160 (Pubitemid 39207051)
51. Moorman P. G., Hulka B. S., Hiatt R. A., Krieger N., Newman B., Vogelman J. H., Orentreich N., Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status Cancer Epidemiology Biomarkers and Prevention 1998 7 6 483 488 (Pubitemid 28354111)
52. Siemianowicz K., Gminski J., Stajszczyk M., Wojakowski W., Goss M., Machalski M., Telega A., Brulinski K., Magiera-Molendowska H., Serum HDL cholesterol concentration in patients with squamous cell and small cell lung cancer International Journal of Molecular Medicine 2000 6 3 307 311
53. Umeki S., Decreases in serum cholesterol levels in advanced lung cancer Respiration 1993 60 3 178 181 (Pubitemid 23250149)
54. Dessi S., Batetta B., Pulisci D., Spano O., Cherchi R., Lanfranco G., Tessitore L., Costelli P., Baccino F. M., Anchisi C., Pani P., Altered pattern of lipid metabolism in patients with lung cancer Oncology 1992 49 6 436 441 (Pubitemid 23003106)
55. Fiorenza A. M., Branchi A., Sommariva D., Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects International Journal of Clinical and Laboratory Research 2000 30 3 141 145 (Pubitemid 32151973)
56. Kucharska-Newton A. M., Rosamond W. D., Schroeder J. C., McNeill A. M., Coresh J., Folsom A. R., HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study Lung Cancer 2008 61 3 292 300
57. Ahn J., Lim U., Weinstein S. J., Schatzkin A., Hayes R. B., Virtamo J., Albanes D., Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer Cancer Epidemiology Biomarkers and Prevention 2009 18 11 2814 2821
58. Tall A. R., An overview of reverse cholesterol transport European Heart Journal 1998 19 A31 A35
59. Von Eckardstein A., Hersberger M., Rohrer L., Current understanding of the metabolism and biological actions of HDL Current Opinion in Clinical Nutrition and Metabolic Care 2005 8 2 147 152 (Pubitemid 40289474)
60. Esteve E., Ricart W., Fernndez-Real J. M., Dyslipidemia and inflammation: an evolutionary conserved mechanism Clinical Nutrition 2005 24 1 16 31
61. Engels E. A., Inflammation in the development of lung cancer: epidemiological evidence Expert Review of Anticancer Therapy 2008 8 4 605 615 (Pubitemid 351818355)
62. Spiegel R. J., Schaefer E. J., Magrath I. T., Edwards B. K., Plasma lipid alterations in leukemia and lymphoma American Journal of Medicine 1982 72 5 775 782 (Pubitemid 12112425)
63. Blackman J. D., Cabana V. G., Mazzone T., The acute-phase response and associated lipoprotein abnormalities accompanying lymphoma Journal of Internal Medicine 1993 233 2 201 204 (Pubitemid 23068324)
64. Lim U., Gayles T., Katki H. A., Stolzenberg-Solomon R., Weinstein S. J., Pietinen P., Taylor P. R., Virtamo J., Albanes D., Serum high-density lipoprotein cholesterol and risk of non-hodgkin lymphoma Cancer Research 2007 67 11 5569 5574 (Pubitemid 46997300)
65. Navab M., Ananthramaiah G. M., Reddy S. T., Van Lenten B. J., Ansell B. J., Hama S., Hough G., Bachini E., Grijalva V. R., Wagner A. C., Shaposhnik Z., Fogelman A. M., The double jeopardy of HDL Annals of Medicine 2005 37 3 173 178 (Pubitemid 40780434)
66. Tietge U. J. F., Maugeais C., Cain W., Rader D. J., Acute inflammation increases selective uptake of HDL cholesteryl esters into adrenals of mice overexpressing human sPLA American Journal of Physiology 2003 285 2 E403 E411
67. Spieker L. E., Ruschitzka F., Lscher T. F., Noll G., HDL and inflammation in atherosclerosis Current Drug Targets Immune, Endocrine and Metabolic Disorders 2004 4 1 51 57 (Pubitemid 38854881)
68. Cockerill G. W., Huehns T. Y., Weerasinghe A., Stocker C., Lerch P. G., Miller N. E., Haskard D. O., Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation Circulation 2001 103 1 108 112 (Pubitemid 32050444)
69. Ansell B. J., Watson K. E., Fogelman A. M., Navab M., Fonarow G. C., High-density lipoprotein function: recent advances Journal of the American College of Cardiology 2005 46 10 1792 1798 (Pubitemid 41579798)
70. Whitehouse P. J., Sciulli C. G., Mason R. M., Dementia drug development: use of information systems to harmonize global drug development Psychopharmacology Bulletin 1997 33 1 129 133 (Pubitemid 27184207)
71. Martins I. J., Hone E., Foster J. K., Snram-Lea S. I., Gnjec A., Fuller S. J., Nolan D., Gandy S. E., Martins R. N., Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease Molecular Psychiatry 2006 11 8 721 736 (Pubitemid 44141805)
72. Xuereb J. H., Brayne C., Dufouil C., Gertz H., Wischik C., Harrington C., Mukaetova-Ladinska E., McGee M. A., O'Sullivan A., O'Connor D., Paykel E. S., Huppert F. A., Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders Annals of the New York Academy of Sciences 2000 903 490 496 (Pubitemid 30251594)
73. Eckert G. P., Kirsch C., Leutz S., Wood W. G., Mller W. E., Cholesterol modulates amyloid beta-peptide's membrane interactions European Archives of Psychiatry and Clinical Neuroscience 2003 252 2 63 67
74. Koudinov A. R., Koudinova N. V., Essential role for cholesterol in synaptic plasticity and neuronal degeneration The FASEB Journal 2001 15 10 1858 1860
75. Guglielmotto M., Giliberto L., Tamagno E., Tabaton M., Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors Front Aging Neuroscience 2010 9 2 3
76. Dominique Ashen M., Blumenthal R. S., Low HDL cholesterol levels New England Journal of Medicine 2005 353 12 1252 1260 (Pubitemid 41345947)
77. Ward M. A., Carlsson C. M., Trivedi M. A., Sager M. A., Johnson S. C., The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study BMC Neurology 2005 5
78. Kramer A. F., Erickson K. I., Colcombe S. J., Exercise, cognition, and the aging brain Journal of Applied Physiology 2006 101 4 1237 1242 (Pubitemid 44497569)
79. Barzilai N., Atzmon G., Derby C. A., Bauman J. M., Lipton R. B., A genotype of exceptional longevity is associated with preservation of cognitive function Neurology 2006 67 12 2170 2175 (Pubitemid 46035472)
80. Singh-Manoux A., Gimeno D., Kivimaki M., Brunner E., Marmot M. G., Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife the whitehall II study Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 8 1556 1562
81. Wahrle S. E., Jiang H., Parsadanian M., Kim J., Li A., Knoten A., Jain S., Hirsch-Reinshagen V., Wellington C. L., Bales K. R., Paul S. M., Holtzman D. M., Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease Journal of Clinical Investigation 2008 118 2 671 682 (Pubitemid 351206556)
82. Olesen O. F., Dag L., High density lipoprotein inhibits assembly of amyloid -peptides into fibrils Biochemical and Biophysical Research Communications 2000 270 1 62 66 (Pubitemid 30440393)
83. Lesn S., Ming T. K., Kotilinek L., Kayed R., Glabe C. G., Yang A., Gallagher M., Ashe K. H., A specific amyloid- protein assembly in the brain impairs memory Nature 2006 440 7082 352 357
84. Hardy J., Cullen K., Amyloid at the blood vessel wall Nature Medicine 2006 12 7 756 757 (Pubitemid 44050057)
85. Kontush A., Amyloid- : an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease Free Radical Biology and Medicine 2001 31 9 1120 1131 (Pubitemid 33000134)
86. Reiss A. B., Siller K. A., Rahman M. M., Chan E. S. L., Ghiso J., De Leon M. J., Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease Neurobiology of Aging 2004 25 8 977 989 (Pubitemid 38798059)
87. Michikawa M., Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease? Journal of Neuroscience Research 2003 72 2 141 146 (Pubitemid 36389880)
88. Wolf H., Hensel A., Arendt T., Kivipelto M., Winblad B., Gertz H. J., Serum lipids and hippocampal volume: the link to Alzheimer's disease? Annals of Neurology 2004 56 5 745 748 (Pubitemid 39540761)
89. Kivipelto M., Ngandu T., Laatikainen T., Winblad B., Soininen H., Tuomilehto J., Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study Lancet Neurology 2006 5 9 735 741 (Pubitemid 44205512)
90. Zuliani G., Ble A., Zanca R., Munari M. R., Zurlo A., Vavalle C., Atti A. R., Fellin R., Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease BMC Geriatrics 2001 1 1 5 (Pubitemid 38870361)
91. Kuriyama M., Takahashi K., Yamano T., Hokezu Y., Togo S., Osame M., Igakura T., Low levels of serum apolipoprotein A I and A II in senile dementia Japanese Journal of Psychiatry and Neurology 1994 48 3 589 593 (Pubitemid 24380694)
92. Muckle T. J., Roy J. R., High-density lipoprotein cholesterol in differential diagnosis of senile dementia The Lancet 1985 1 8439 1191 1193 (Pubitemid 15083674)
93. Van Exel E., De Craen A. J. M., Gussekloo J., Houx P., Bootsma-Van Der Wiel A., Macfarlane P. W., Blauw G. J., Westendorp R. G. J., Association between high-density lipoprotein and cognitive impairment in the oldest old Annals of Neurology 2002 51 6 716 721 (Pubitemid 34568850)
94. Sacco R. L., Benson R. T., Kargman D. E., Boden-Albala B., Tuck C., Lin I. F., Cheng J. F., Paik M. C., Shea S., Berglund L., High-density lipoprotein cholesterol and ischemic stroke in the elderly the northern manhattan stroke study Journal of the American Medical Association 2001 285 21 2729 2735 (Pubitemid 32525369)
95. Romas S. N., Tang M. X., Berglund L., Mayeux R., APOE genotype, plasma lipids, lipoproteins, and AD in community elderly Neurology 1999 53 3 517 521 (Pubitemid 29382044)
96. Reitz C., Tang M. X., Luchsinger J., Mayeux R., Relation of plasma lipids to Alzheimer disease and vascular dementia Archives of Neurology 2004 61 5 705 714 (Pubitemid 38637688)
97. Li G., Shofer J. B., Kukull W. A., Peskind E. R., Tsuang D. W., Breitner J. C. S., McCormick W., Bowen J. D., Teri L., Schellenberg G. D., Larson E. B., Serum cholesterol and risk of Alzheimer disease: a community-based cohort study Neurology 2005 65 7 1045 1050 (Pubitemid 41429629)
98. Abbott R. D., Sharp D. S., Burchfiel C. M., Curb J. D., Rodriguez B. L., Hakim A. A., Yano K., Cross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart Program Annals of Epidemiology 1997 7 6 417 424
99. Ferrara A., Barrett-Connor E., Shan J., Total, LDL, and HDL cholesterol decrease with age in older men and women: the Rancho Bernardo Study 19841994 Circulation 1997 96 1 37 43 (Pubitemid 27298401)
100. Kawano M., Kawakami M., Otsuka M., Yashima H., Yaginuma T., Ueki A., Marked decrease of plasma apolipoprotein AI and AII in Japanese patients with late-onset non-familial Alzheimer's disease Clinica Chimica Acta 1995 239 2 209 211
101. Merched A., Xia Y., Visvikis S., Serot J. M., Siest G., Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease Neurobiology of Aging 2000 21 1 27 30 (Pubitemid 30224782)
102. Saczynski J. S., White L., Peila R. L., Rodriguez B. L., Launer L. J., The relation between apolipoprotein A-I and dementia: the honolulu-asia aging study American Journal of Epidemiology 2007 165 9 985 992 (Pubitemid 46598838)